AkornのEPS Q / Q
AkornのEPS Q / Qは何ですか。
Akorn, Inc.のEPS Q / Qは950.00%です。
EPS Q / Qの定義は何ですか。
四半期EPS成長率(Quarterly EPS growth rate)は、過去4四半期の業績と比較して過去4四半期のEPSの増加です。
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
OTCのセクタHealth CareにおけるEPS Q / Qの企業と比べるAkorn
Akornは何をしますか。
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Akornと類似のeps q / q
- Astria Therapeutics IncのEPS Q / Qは907.55%です。
- Millendo TherapeuticsのEPS Q / Qは915.38%です。
- Veru IncのEPS Q / Qは920.00%です。
- Alpine Income Property Trust IncのEPS Q / Qは928.57%です。
- Boeing CoのEPS Q / Qは930.00%です。
- Coca-Cola Femsa S.A.B. DE C.VのEPS Q / Qは930.00%です。
- AkornのEPS Q / Qは950.00%です。
- Bright Scholar Education LtdのEPS Q / Qは962.50%です。
- Zentalis Pharmaceuticals, LlcのEPS Q / Qは966.67%です。
- Teranga GoldのEPS Q / Qは1,000.00%です。
- WeCommerceのEPS Q / Qは1,000.00%です。
- Nordex SEのEPS Q / Qは1,014.29%です。
- BonavistaのEPS Q / Qは1,046.67%です。